Clinical Therapy Effects and Safety Studies of Prednisone Acetate Tablets in Patients with Tuberculous More Serous Cavity Effusion
Author:ZHANG Quan-wu
affiliation: Shaanxi Tuberculosis Prevention and Treatment Hospital, Xi'an 710000, Shaanxi Province, China
PDFAbstract
Objective Evaluate the clinical treatment effect of prednisone acetate in tuberculous patients with more serous cavity effusion. Methods Select 60 tuberculous patients with more serous cavity effusion who diagnosis and treatment in our hospital from April 2014 - April 2016. The 60 patients were divided into control group of 30 patients and observation group of 30 patients according to the different therapy. The control group adopts 3hrez/15hre plan anti-tuberculosis treatment, the observation group adopts therapy with prednisone acetate tablets on the basis of the control group. Results Compare clinical curative effect of the two groups, the observation group therapy efficacy rate was 93.3%, higher than 80.0% in the control group (P<0.05) the incidence of adverse reactions in observation group was 13.33%, significantly less than 30.00% of the control group (P<0.05). Conclusion Tuberculous patients with more serous cavity effusion combined therapy with prednisone acetate tablets is more effective compared with single TB solution treatment, this treatment plan is worth popularization and application.
【Keyword】Prednisone Acetate Tablets; Anti-tuberculosis Treatment; Tuberculous More Serous Cavity Effusion
【Chart number】R521;R978.3
【Document Identification Number】A
【DOI】10.3969/j.issn.1009-3257.2016.06.008
Journal of Rare Diseases
th23Volume, th 2 Issue
2019Year11Month
Related articles